Cart
sales@molnova.com
WAY-297848
CAS No. 404360-27-6
WAY-297848( —— )
Catalog No. M37120 CAS No. 404360-27-6
WAY-297848 is a novel glucokinase activator for the prevention or treatment of hyperglycemia, diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 34 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 80 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-297848
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-297848 is a novel glucokinase activator for the prevention or treatment of hyperglycemia, diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome.
-
DescriptionWAY-297848 is an active molecule for the study of amyloid diseases and synucleinopathies.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
RecptorGlucokinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404360-27-6
-
Formula Weight296.77
-
Molecular FormulaC13H13ClN2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=NC=CS1)C(OC2=CC=C(Cl)C=C2)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Hexestrol
Hexestrol binds to ERα and ERβ with EC50 of 0.07 nM and 0.175 nM, respectively.
-
Allylglucosinolate m...
Sinigrin exerts important anti-proliferative activities in carcinogen-induced hepatocarcinogenesis in rats, and highlight the potential of Sinigrin as an anti-cancer agent for liver cancer.
-
ML266
ML266, a glucocerebrosidase (GCase) chaperone with an IC50 of 2.5 μM, facilitates the transport of the mutant protein to the lysosome, thereby restoring GCase activity without inhibiting the enzyme's function.
